Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections
- 1 June 1990
- Vol. 71 (2) , 131-133
- https://doi.org/10.1016/0041-3879(90)90009-w
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Single Daily-dose Ofloxacin Monotherapy for Mycobacterium fortuitum Sternotomy InfectionChest, 1989
- Combination of Ofloxacin and Amikacin in the Treatment of Sternotomy Wound InfectionChest, 1989
- Ofloxacin and the Treatment of Pulmonary Disease due to Mycobacterium fortuitumChest, 1987
- In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- OfloxacinDrugs, 1987
- In-vitro activity of some quinoline derivatives against MycobacteriumfortuitumJournal of Antimicrobial Chemotherapy, 1985
- In VitroAntimycobacterial Activity of a New Antibacterial Substance DL-8280-Differentiation between Some Species of Mycobacteria and Related Organisms by the DL-8280 Susceptibility TestMicrobiology and Immunology, 1983
- Antimicrobial Susceptibility Testing of Mycobacterium fortuitum ComplexAntimicrobial Agents and Chemotherapy, 1979
- Activity of amikacin, erythromycin and doxycycline against mycobacterium chelonei and mycobacterium fortuitumTubercle, 1978
- In Vitro Susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to AmikacinThe Journal of Infectious Diseases, 1978